Quantification and prognostic significance of interferon-γ secreting SARS-CoV-2 responsive T cells in hospitalized patients with acute COVID-19 - 02/03/22

Daniel Pan ^{a, b,} 1

  Daniel Pan, Jee Whang Kim and Joshua Nazareth are joint first authors.

, ^⁎ , Jee Whang Kim ^{a, c,} 1

  Daniel Pan, Jee Whang Kim and Joshua Nazareth are joint first authors.

, Joshua Nazareth ^{a, b,} 1

  Daniel Pan, Jee Whang Kim and Joshua Nazareth are joint first authors.

, Sara Assadi ^b, Adam Bellass ^b, Jack Leach ^d, James G Brosnan ^d, Adam Ahmed ^d, Fleur Starcevic ^b, Shirley Sze ^e, Christopher A Martin ^{a, b}, Caroline M Williams ^{a, f}, Michael R Barer ^{a, f}, Amandip Sahota ^b, Prashanth Patel ^g, Andrea Tattersall ^h, Andrea Cooper ^{a, i}, Manish Pareek ^{a, b,} 2

  Manish Pareek and Pranabashis Haldar are joint senior authors.

, Pranabashis Haldar ^{a, c,} 2

  Manish Pareek and Pranabashis Haldar are joint senior authors.

^a Department of Respiratory Sciences, University of Leicester, United Kingdom 

^b Department of Infectious Diseases and HIV Medicine, University Hospitals of Leicester NHS Trust, United Kingdom 

^c Respiratory Biomedical Research Center, University of Leicester, United Kingdom 

^d University of Leicester Medical School, United Kingdom 

^e Department of Cardiovascular Sciences, University of Leicester, United Kingdom 

^f Department of Microbiology, University Hospitals of Leicester NHS Trust, United Kingdom 

^g Department of Chemical and Metabolic Diseases, University Hospitals of Leicester NHS Trust, United Kingdom 

^h Oxford Immunotec Ltd, United Kingdom 

ⁱ Trudeau Institute, Saranac Lake, New York, USA 

^⁎Corresponding author at: Department of Respiratory Sciences, University of Leicester, United Kingdom.Department of Respiratory SciencesUniversity of LeicesterUnited Kingdom

Le texte complet de cet article est disponible en PDF.